# New clinical trials in Ireland: 241 since Nov 2024

Updated November 5, 2026.

241 clinical studies with a site in Ireland were first posted on ClinicalTrials.gov from November 12, 2024 to November 5, 2026; 110 have an industry sponsor and 176 are recruiting or about to. The newest, NCT07917780, was posted on November 5, 2026: A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib... (German CLL Study Group).

## The full list

New clinical trials with a site in Ireland: 241 rows for $12.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/country/ireland

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 241
- Industry sponsored: 110
- Recruiting or not yet: 176
- Latest posted: November 5, 2026

## Newest trials

The newest 100 of 241, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07917780 | A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With... | German CLL Study Group | Phase 2 | Recruiting | Richter Transformation | 116 | Australia, Austria, Denmark, Germany, Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917780) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07908290 | Shower Gel and Participant-Reported Post-Exercise Soreness in Regular Exercisers | The Humanix | Not applicable | Recruiting | Post-Exercise Recovery, Muscle Soreness | 100 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908290) |
| November 2, 2026 | NCT07908238 | Maximising Maternal Milk for Preterm Infant | National Maternity Hospital, Ireland | Not applicable | Recruiting | Breastfeeding, Prematurity | 160 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908238) |
| October 19, 2026 | NCT07880431 | Intelligent Physiological Monitoring to Predict Preterm Brain Injury | University College Cork | Observational | Enrolling by invitation | Cerebral Palsy (CP), Intraventricular Hemorrhage Neonatal, Periventricular Leukomalacia, Neurodevelopmental Delay | 413 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880431) |
| October 5, 2026 | NCT07857070 | Newborn Brain Assessment - CergenX Wave | CergenX Limited | Observational | Not yet recruiting | Neonatal Encephalopathy, Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy), Neonatal Encephalopathy... | 165 | Ireland, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857070) |
| October 2, 2026 | NCT07854899 | Natural History Study of Advanced RCD | SparingVision | Not applicable | Recruiting | Rod Cone Dystrophy | 100 | Belgium, France, Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854899) |
| October 1, 2026 | NCT07852897 | Evaluation of Commercially Available Heel Pads for the Prevention of Pressure Ulcers: An Observational Study of Incidence and Usability in... | Trulife | Observational | Enrolling by invitation | Pressure Injury Prevention | 35 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852897) |
| September 25, 2026 | NCT07840534 | Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU) | University College Cork | Not applicable | Not yet recruiting | Breast Cancer, Breast Cancer Survivorship, Cancer Survivorship, Endocrine Therapy, Early Stage Breast Cancer | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840534) |
| September 8, 2026 | NCT07807111 | Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy | SparingVision | Phase 1/2 | Recruiting | Retinitis Pigmentosa (RP), Rod Cone Dystrophy | 27 | Belgium, France, Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807111) |
| September 1, 2026 | NCT07798674 | TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias | Heidelberg University | Observational | Recruiting | Hereditary Spastic Paraplegia, Spastic Ataxia | 4,000 | Austria, Czechia, France, Germany, Ireland, Italy, Netherlands, Poland, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07798674) |
| August 28, 2026 | NCT07789483 | An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy | Alexion Pharmaceuticals, Inc. | Phase 3 | Not yet recruiting | Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 1,180 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789483) |
| August 20, 2026 | NCT07777614 | OPTIMISE Lung SABR | Cancer Trials Ireland | Phase 2 | Recruiting | Non Small Cell Lung Cancer | 208 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777614) |
| August 18, 2026 | NCT07770035 | School-aged Outcomes Post Hypoxic Ischaemic Encephalopathy | University College Cork | Observational | Enrolling by invitation | Hypoxic-Ischemic Encephalopathy | 196 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770035) |
| August 17, 2026 | NCT07769021 | Tracheostomy Practice in Adult Intensive Care Units | Royal College of Surgeons, Ireland | Observational | Not yet recruiting | Tracheostomy Patients, Tracheostomy Decannulation, Intensive Care (ICU) | 2,500 | Brazil, Canada, India, Ireland, Italy, Switzerland, United Kingdom, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769021) |
| August 12, 2026 | NCT07761130 | A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP) | University of Limerick | Not applicable | Completed | Stroke | 19 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761130) |
| August 12, 2026 | NCT07759908 | Effects of a Synbiotic Intervention on Perimenopausal/Menopausal Symptoms | University College Cork | Not applicable | Completed | Menopause, Perimenopause, Perimenopausal Women | 49 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759908) |
| August 5, 2026 | NCT07746609 | The Design and Evaluation of a Digital Physical Activity Intervention for Individuals With Severe Mental Illness in an Irish Mental Health... | Munster Technological University | Not applicable | Completed | Severe Mental Illness, Health Professionals | 18 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746609) |
| July 29, 2026 | NCT07734532 | Infant Formula Study With Pre- And Postbiotics | Nutricia UK Ltd | Not applicable | Completed | Formula Milk, Infants | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734532) |
| July 28, 2026 | NCT07731555 | Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological... | Patrick Morris | Not applicable | Recruiting | Glioblastoma | 100 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731555) |
| July 23, 2026 | NCT07721766 | Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training | Technical University of Munich | Not applicable | Recruiting | Healthy Volunteers, Muscle Hypertrophy, Glycolysis, Moderately Trainend | 120 | Finland, Germany, Ireland, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721766) |
| July 1, 2026 | NCT07679490 | Probiotic in Fruit Snack | University College Dublin | Not applicable | Active not recruiting | Colonization, Asymptomatic, Probiotic Intervention, Gut Microbiota Diversity and Composition, Gut-brain Axis | 25 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07679490) |
| June 26, 2026 | NCT07672392 | The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep... | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Breast Cancer, Exercise | 78 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07672392) |
| June 9, 2026 | NCT07636395 | Eating Behaviour Before, During, and After Obesity Medication | University College Dublin | Observational | Recruiting | Obesity Type 2 Diabetes Mellitus, Obesity & Overweight | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636395) |
| June 5, 2026 | NCT07628608 | Safety and User Experience of BP-CBB | Bactolife A/S | Not applicable | Active not recruiting | Safety and Tolerability in Healthy Volunteers | 60 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628608) |
| June 3, 2026 | NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib | Takeda | Phase 3 | Recruiting | Myelofibrosis, Anemia | 324 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623161) |
| June 1, 2026 | NCT07616258 | Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Primary Breast Cancer | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Breast Cancer | 560 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616258) |
| June 1, 2026 | NCT07616245 | MCT Enteral Feeding to Reduce Chyle Leak After Oesophagectomy | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Oesphageal Cancer | 160 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616245) |
| May 27, 2026 | NCT07609134 | The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Asthma, Self-management, Asthma Control | 40 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609134) |
| May 26, 2026 | NCT07605936 | Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study | University of Limerick | Observational | Recruiting | Frailty at Older Adults, Prostate Cancer | 80 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07605936) |
| May 20, 2026 | NCT07600229 | Barefoot Walking VS Standardised Conservative Care for Plantar Fasciopathy | Elisabetta Brigo | Not applicable | Recruiting | Plantar Fasciopathy, Plantar Fasciitis, Plantar Fasciitis, Chronic, Heel Pain | 74 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600229) |
| May 18, 2026 | NCT07592234 | Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events | St Vincent's University Hospital, Ireland | Observational | Recruiting | Serious Adverse Events, Patient Safety, Pharmacovigilance, Oncology | 100 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592234) |
| May 14, 2026 | NCT07586930 | CP: Intestinal Permeability | Rousselot BVBA | Not applicable | Recruiting | Intestinal Permability | 92 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07586930) |
| May 13, 2026 | NCT07585149 | Generating Intervals of Reference FFor Early Life Brain Biomarkers. | University College Cork | Observational | Recruiting | Reference Intervals, Biomarker in Early Diagnosis, Neonatal | 150 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07585149) |
| May 12, 2026 | NCT07581392 | Reintervention Rates and Complications in Endovascular Aneurysm Repair (EVAR) and the Use of Colour Doppler Ultrasound (CDUS) and Computed... | University Hospital of Limerick | Observational | Completed | Aneurysm Abdominal | 405 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581392) |
| May 11, 2026 | NCT07577609 | AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION) | University of Galway | Observational | Recruiting | Coronary Artery Disease (CAD), Computed Tomography Angiography, Biomarkers, AI (Artificial Intelligence)... | 10,000 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577609) |
| May 8, 2026 | NCT07575269 | Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation | Boston Scientific Corporation | Not applicable | Recruiting | Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation | 571 | Belgium, Ireland, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575269) |
| May 7, 2026 | NCT07572370 | Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer | Royal College of Surgeons, Ireland | Observational | Recruiting | Breast Cancer | 560 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572370) |
| May 5, 2026 | NCT07566884 | Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults | Pendulum Therapeutics | Not applicable | Active not recruiting | Healthy Adults | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07566884) |
| May 1, 2026 | NCT07561957 | A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD)... | St. James's Hospital, Ireland | Not applicable | Recruiting | Chronic Kidney Disease, Proteinuria, Blood Pressure Control, Congenital Anomalies of the Kidneys and Urinary Tract... | 80 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561957) |
| April 30, 2026 | NCT07559643 | The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial. | University College Dublin | Not applicable | Not yet recruiting | Bariatric Surgery, Anti-Xa Activity, VTE (Venous Thromboembolism), Obesity & Overweight | 180 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559643) |
| April 30, 2026 | NCT07558668 | A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis | Sitryx Therapeutics Ltd | Phase 1 | Recruiting | Moderate to Severe Atopic Dermatitis | 149 | Bulgaria, Denmark, Germany, Ireland, United Kingdom, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558668) |
| April 29, 2026 | NCT07555483 | A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With... | Grifols Therapeutics LLC | Phase 3 | Recruiting | Alpha 1 Antitrypsin Deficiency | 40 | Denmark, Germany, Ireland, Netherlands, Poland, Portugal, Spain, Sweden, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555483) |
| April 27, 2026 | NCT07552168 | INSPIRE: INnovative SABR for Prostate Cancer All IREland | Cancer Trials Ireland | Phase 2 | Recruiting | Prostate Adenocarcinoma | 136 | Ireland, United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07552168) |
| April 22, 2026 | NCT07546500 | A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian... | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Phase 3 | Recruiting | Ovarian Cancer | 420 | Argentina, Australia, Belgium, Brazil, Canada, Croatia, Denmark, Estonia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546500) |
| April 21, 2026 | NCT07541170 | A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in... | Hoffmann-La Roche | Phase 3 | Recruiting | Non-small Cell Lung Cancer | 400 | Argentina, Belgium, Brazil, Canada, China, Colombia, France, Germany, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07541170) |
| April 13, 2026 | NCT07524595 | Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve... | National University of Ireland, Galway, Ireland | Not applicable | Not yet recruiting | AORTIC VALVE DISEASES, Valve-in-valve Procedures, Surgical Valve Replacement, Valve Disease, Aortic | 111 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524595) |
| April 13, 2026 | NCT07524517 | NeoSHARK: Anatomical Versus Round Facemasks for Breathing Support in Preterm and Term Newborn Infants | University College Dublin | Not applicable | Recruiting | Neonatal Intensive Care | 50 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524517) |
| April 13, 2026 | NCT07523620 | Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration | Abbott Medical Devices | Not applicable | Recruiting | Atrial Fibrillation (AF), Paroxysmal AF, Persistent Atrial Fibrillation | 240 | Belgium, Czechia, Denmark, Germany, Ireland, Italy, Lithuania, Poland, Spain... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523620) |
| April 9, 2026 | NCT07519967 | Efficacy of Lactobacillus Mucosae DPC6426 on Blood-lipids | University College Cork | Not applicable | Completed | Cholesterol, Hypercholesterolaemia | 94 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07519967) |
| April 6, 2026 | NCT07512505 | Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor | Our Lady's Hospice and Care Services | Observational | Recruiting | Cancer, Malignancies Multiple, Terminal Care, Hospice | 120 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07512505) |
| April 2, 2026 | NCT07508670 | An Observational Study of the NeuroBell EEG Monitor | University College Cork | Observational | Completed | EEG, Neonatology, Seizure, Neurology, Hypoxic Ischaemic Encephalopathy (HIE), Neonatal Seizures, Medical Devices | 17 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07508670) |
| April 2, 2026 | NCT07507500 | Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Phase 4 | Recruiting | Myocardial Infarction (MI) | 8,100 | Ireland, Latvia, Norway, Poland, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507500) |
| April 1, 2026 | NCT07505329 | An Intervention Study in Healthy Infants Aged 0-6 Months With Probiotics Lacticaseibacillus Rhamnosus LRa05 (LRa05) and Bifidobacterium... | University College Cork | Not applicable | Not yet recruiting | Less Than 3 Months Old, Healthy Infants | 300 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505329) |
| March 31, 2026 | NCT07503717 | SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System... | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Breast Cancer, HER2-Positive Metastatic Breast Cancer | 69 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07503717) |
| March 31, 2026 | NCT07503704 | A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived... | Royal College of Surgeons, Ireland | Observational | Recruiting | Breast Cancer | 69 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07503704) |
| March 25, 2026 | NCT07492680 | A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic... | Bristol-Myers Squibb | Phase 2 | Recruiting | Solid Tumors | 254 | Belgium, Canada, China, France, Germany, Hong Kong, Ireland, Italy, Japan... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492680) |
| March 24, 2026 | NCT07489521 | Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis | Cappagh National Orthopaedic Hospital | Phase 4 | Recruiting | Osteo Arthritis Knee, Osteoarthritis, Intraarticular Injection | 200 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07489521) |
| March 18, 2026 | NCT07481240 | A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families | University College Cork | Not applicable | Completed | Vitamin D Deficiency | 128 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481240) |
| March 17, 2026 | NCT07477938 | A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability | National University of Ireland, Galway, Ireland | Not applicable | Not yet recruiting | Cancer Awareness and Prevention Education, Breast Cancer Awareness, Intellectual Disabilities (F70-F79) | 25 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07477938) |
| March 17, 2026 | NCT07476807 | Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study | Sligo General Hospital | Not applicable | Enrolling by invitation | Rash, Systemic Treatments, Tele-assessment | 25 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476807) |
| March 16, 2026 | NCT07472517 | DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and... | Boehringer Ingelheim | Phase 3 | Recruiting | Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 670 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472517) |
| March 9, 2026 | NCT07457424 | Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT) | University College Dublin | Observational | Active not recruiting | Metabolic Disease, Obesity & Overweight | 140 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07457424) |
| March 6, 2026 | NCT07455422 | A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect... | University Hospital, Antwerp | Not applicable | Not yet recruiting | Barrett Esophagus, Barrett Esophagus Adenocarcinoma, Adenocarcinoma - GEJ, Gastroenterology, Gastroenterological Cancer | 266 | Belgium, Denmark, France, Germany, Ireland, Italy, Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07455422) |
| March 6, 2026 | NCT07453823 | The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals | Chr Hansen - part of Novonesis | Not applicable | Recruiting | Gastrointestinal Microbiome (Focus), Gastrointestinal Symptoms | 90 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07453823) |
| March 6, 2026 | NCT07453498 | Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty | University College Hospital Galway | Not applicable | Recruiting | Total Hip Arthroplasty (THA) | 130 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07453498) |
| March 2, 2026 | NCT07443579 | Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Breast Cancer, Breast Cancer Recurrence, Post Treatment Surveillance | 400 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07443579) |
| March 2, 2026 | NCT07441408 | Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis | Bristol-Myers Squibb | Phase 3 | Not yet recruiting | Pulmonary Fibrosis | 2,380 | Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07441408) |
| February 27, 2026 | NCT07434804 | Exploring the Feasibility of Using Virtual Reality as an Educational Tool in Chronic Pain Rehabilitation | University College Dublin | Not applicable | Not yet recruiting | Pain, Chronic Pain, Chronic Pain (Back / Neck), Adults, Virtual Reality, Neuroscience Pain Education | 50 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07434804) |
| February 23, 2026 | NCT07426874 | eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors | Royal College of Surgeons, Ireland | Not applicable | Active not recruiting | Head and Neck Cancer (H&N) | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426874) |
| February 23, 2026 | NCT07426861 | Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Prostate Cancer, Urinary Incontinence, Postoperative Complications, Radical Prostatectomy | 80 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426861) |
| February 23, 2026 | NCT07426848 | OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Primary Brain Tumour, Glioblastoma, Brain Neoplasms | 96 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426848) |
| February 23, 2026 | NCT07426835 | The PHARO Trial: The Incidence of Para-conduit Hernia With Closure of Hiatus Versus the Standard Approach in Robotic Oesophagectomy - A... | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Oesphageal Cancer, Para-conduit Hernia | 40 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426835) |
| February 23, 2026 | NCT07426809 | Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). | Royal College of Surgeons, Ireland | Not applicable | Recruiting | Breast Cancer | 314 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426809) |
| February 20, 2026 | NCT07425002 | Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM) | Cancer Trials Ireland | Not applicable | Recruiting | Breast Cancer | 1,600 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07425002) |
| February 20, 2026 | NCT07422727 | Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy | Sligo General Hospital | Not applicable | Enrolling by invitation | Hot Flashes, Sleep, Hormonal, Cancer | 40 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422727) |
| February 20, 2026 | NCT07422480 | A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need... | Takeda | Phase 3 | Recruiting | Myelodysplastic Syndrome, Anemia | 300 | Argentina, Australia, Belgium, Brazil, Bulgaria, France, Germany, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422480) |
| February 19, 2026 | NCT07420023 | The Satiety Control Optimization by Nutritional Enhancement Study | University College Cork | Not applicable | Recruiting | Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease | 24 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07420023) |
| February 18, 2026 | NCT07417254 | Novel Personalised Nutrition Intervention With Tailored Behavioural Support | University College Dublin | Not applicable | Completed | Behavior Change, Dietary Behaviour, Personalised Nutrition, Sustainable Healthy Diet, Behavior And Behavior Mechanism... | 66 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07417254) |
| February 18, 2026 | NCT07417228 | The Impact of Concurrent Training on Women Experiencing Symptoms of Menopause | University College Dublin | Not applicable | Recruiting | Menopause Symptoms | 90 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07417228) |
| February 18, 2026 | NCT07416604 | A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A | Hoffmann-La Roche | Phase 3 | Recruiting | Hemophilia A | 360 | Argentina, Australia, Belgium, Brazil, Canada, China, Denmark, France, Germany... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07416604) |
| February 13, 2026 | NCT07411105 | Cognition in Older Adults With Cancer Receiving Systemic Anti-Cancer Therapy | Our Lady's Hospice and Care Services | Observational | Active not recruiting | Cancer, Older Adults (65 Years and Older), Cognition | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07411105) |
| February 12, 2026 | NCT07407530 | Comparison of 'Sip Til Send' Regimens Prior to Elective Caesarean Delivery Using Bedside Gastric Ultrasound | The Rotunda Hospital | Not applicable | Recruiting | Gastric Emptying, Caesarean Delivery, Pregnancy | 190 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07407530) |
| February 11, 2026 | NCT07402915 | Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | AstraZeneca | Phase 1 | Recruiting | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal | 32 | Georgia, Ireland, Portugal, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07402915) |
| February 10, 2026 | NCT07401550 | Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics. | University College Dublin | Observational | Recruiting | Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention, Cardiovascular Disease Risk Factor, Coronary Artery... | 100 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401550) |
| February 9, 2026 | NCT07397975 | Speech-based Assessment of Relapse Risk in People With Psychosis | Philipp Homan | Observational | Recruiting | Psychotic Disorder | 360 | Czechia, Ireland, Netherlands, Norway, Switzerland, Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397975) |
| February 6, 2026 | NCT07393880 | Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus | University of Dublin, Trinity College | Not applicable | Recruiting | Tinnitus, Subjective, Tinnitus, Chronic Tinnitus | 100 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07393880) |
| February 4, 2026 | NCT07386483 | Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome | University College Dublin | Not applicable | Not yet recruiting | Psychosis | 40 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07386483) |
| January 29, 2026 | NCT07376746 | Improving ADHD Symptoms and Quality of Life Through Diet | University College Cork | Not applicable | Not yet recruiting | ADHD | 200 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376746) |
| January 26, 2026 | NCT07367100 | A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke | Neuravi Limited | Not applicable | Recruiting | Ischemic Stroke | 74 | Belgium, France, Germany, Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07367100) |
| January 23, 2026 | NCT07363928 | A Digital Cognitive Behavioural Therapy for Insomnia Intervention in Mild Cognitive Impairment and Mild Dementia | University College Cork | Not applicable | Completed | Dementia, Mild Cognitive Impairment, Insomnia, Sleep | 30 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363928) |
| January 23, 2026 | NCT07361497 | A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III... | Bristol-Myers Squibb | Phase 3 | Recruiting | Non-small Cell Lung Cancer (NSCLC) | 850 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07361497) |
| January 22, 2026 | NCT07360847 | Profiling Patients With Rotator Cuff Related Shoulder Pain: What Factors Influence Outcomes With Non-operative Care in a Secondary Care... | University of Limerick | Observational | Recruiting | Rotator Cuff Related Shoulder Pain, RCRSP | 150 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07360847) |
| January 22, 2026 | NCT07359846 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | Argentina, Australia, Belgium, Estonia, France, Georgia, India, Ireland, Italy... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359846) |
| January 20, 2026 | NCT07351526 | Inpatient Post-Acute Rehabilitation For Patients in the Midwest: a Prospective Cohort Study of Clinical Characteristics and Process Outcomes | University of Limerick | Observational | Recruiting | Rehabilitation, Frailty, Complex Patients in Rehabilitation Phase | 100 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07351526) |
| January 16, 2026 | NCT07347912 | Group-based Resistance Training for Adults With Down Syndrome | Saint John of God Intellectual Disability Services - Dublin South East | Not applicable | Active not recruiting | Down Syndrome, Healthy Aging, Resistance Training | 36 | Ireland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07347912) |
| January 13, 2026 | NCT07335497 | CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Crescent Biopharma, Inc. | Phase 1/2 | Recruiting | Locally Advanced / Metastatic Solid Tumors | 540 | Australia, France, Ireland, Italy, Romania, South Korea, Spain, United Kingdom... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335497) |
| January 12, 2026 | NCT07332091 | Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis | CSL Behring | Phase 2 | Active not recruiting | Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis | 84 | Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332091) |
| January 7, 2026 | NCT07322003 | Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS | Prilenia | Phase 3 | Recruiting | Amyotrophic Lateral Sclerosis | 500 | Belgium, Canada, France, Germany, Ireland, Israel, Italy, Netherlands, Poland... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322003) |
| January 6, 2026 | NCT07318558 | A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Ovarian Neoplasms, Ovarian Cancer | 900 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318558) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Royal College of Surgeons, Ireland | 24 | August 17, 2026 |
| University College Cork | 22 | October 19, 2026 |
| University College Dublin | 17 | July 1, 2026 |
| Merck Sharp & Dohme LLC | 8 | January 6, 2026 |
| University of Limerick | 7 | August 12, 2026 |
| Bristol-Myers Squibb | 6 | March 25, 2026 |
| AstraZeneca | 5 | February 11, 2026 |
| University of Dublin, Trinity College | 5 | February 6, 2026 |
| Boehringer Ingelheim | 4 | November 4, 2026 |
| Eli Lilly and Company | 4 | December 17, 2025 |
| Cancer Trials Ireland | 3 | August 20, 2026 |
| University of Galway | 3 | May 11, 2026 |
| Boston Scientific Corporation | 3 | May 8, 2026 |
| Hoffmann-La Roche | 3 | April 21, 2026 |
| Our Lady's Hospice and Care Services | 3 | April 6, 2026 |
| Medtronic Vascular | 3 | August 11, 2025 |
| Connolly Hospital Blanchardstown | 3 | August 5, 2025 |
| SparingVision | 2 | October 2, 2026 |
| Takeda | 2 | June 3, 2026 |
| St. James's Hospital, Ireland | 2 | May 1, 2026 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Breast Neoplasms](https://specstream.ai/data/clinical-trials/condition/breast-neoplasms) | 19 | September 25, 2026 |
| [Carcinoma, Non-Small-Cell Lung](https://specstream.ai/data/clinical-trials/condition/carcinoma-non-small-cell-lung) | 12 | August 20, 2026 |
| [Neoplasms](https://specstream.ai/data/clinical-trials/condition/neoplasms) | 8 | May 18, 2026 |
| [Lung Neoplasms](https://specstream.ai/data/clinical-trials/condition/lung-neoplasms) | 7 | August 20, 2026 |
| [Motor Activity](https://specstream.ai/data/clinical-trials/condition/motor-activity) | 7 | August 5, 2026 |
| [Ovarian Neoplasms](https://specstream.ai/data/clinical-trials/condition/ovarian-neoplasms) | 7 | April 22, 2026 |
| [Cardiovascular Diseases](https://specstream.ai/data/clinical-trials/condition/cardiovascular-diseases) | 6 | February 19, 2026 |
| [Prostatic Neoplasms](https://specstream.ai/data/clinical-trials/condition/prostatic-neoplasms) | 5 | May 26, 2026 |
| [Premature Birth](https://specstream.ai/data/clinical-trials/condition/premature-birth) | 4 | November 2, 2026 |
| [Obesity](https://specstream.ai/data/clinical-trials/condition/obesity) | 4 | June 9, 2026 |
| [Frailty](https://specstream.ai/data/clinical-trials/condition/frailty) | 4 | May 26, 2026 |
| [Atrial Fibrillation](https://specstream.ai/data/clinical-trials/condition/atrial-fibrillation) | 4 | May 8, 2026 |
| Fallopian Tube Neoplasms | 4 | February 11, 2026 |
| [Neoplasm Metastasis](https://specstream.ai/data/clinical-trials/condition/neoplasm-metastasis) | 4 | January 13, 2026 |
| [Amyotrophic Lateral Sclerosis](https://specstream.ai/data/clinical-trials/condition/amyotrophic-lateral-sclerosis) | 4 | January 7, 2026 |
| [Diabetes Mellitus](https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus) | 4 | December 24, 2025 |
| [Hypertension](https://specstream.ai/data/clinical-trials/condition/hypertension) | 4 | August 11, 2025 |
| [Cerebral Palsy](https://specstream.ai/data/clinical-trials/condition/cerebral-palsy) | 3 | October 19, 2026 |
| Hypoxia-Ischemia, Brain | 3 | August 18, 2026 |
| [Overweight](https://specstream.ai/data/clinical-trials/condition/overweight) | 3 | June 9, 2026 |
| [Asthma](https://specstream.ai/data/clinical-trials/condition/asthma) | 3 | May 27, 2026 |
| [Coronary Artery Disease](https://specstream.ai/data/clinical-trials/condition/coronary-artery-disease) | 3 | May 11, 2026 |
| [Renal Insufficiency, Chronic](https://specstream.ai/data/clinical-trials/condition/renal-insufficiency-chronic) | 3 | May 1, 2026 |
| [Pulmonary Disease, Chronic Obstructive](https://specstream.ai/data/clinical-trials/condition/pulmonary-disease-chronic-obstructive) | 3 | April 29, 2026 |
| Idiopathic Pulmonary Fibrosis | 3 | March 2, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 100 | November 2, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 54 | November 4, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 43 | October 19, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 18 | November 5, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 8 | September 8, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 7 | April 2, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 6 | April 30, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 5 | October 2, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).